Select for export Psychedelic use and bipolar disorder - An investigation of recreational use and its impact on mental health. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2024.12.044 PubMed 39675677 Copy citation Copy BibTeX Unknown journal 2024-12-12 Meyer TD, Ibrahim M, Vale LN, Soares JC. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Chronic pain education: past, present, and future of psychedelics for the management of chronic pain Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/pm/pnae124 PubMed 39658247 Copy citation Copy BibTeX Pain Medicine 2024-12-09 Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather OpenAlex Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852924002268 PubMed 39655426 Copy citation Copy BibTeX Unknown journal 2024-12-09 Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A Europe PMC Published psilocybin DepressionAnxietyPTSD Review Article More
Select for export Treatment Expectancies and Psilocybin vs Escitalopram for Depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamapsychiatry.2024.4387 PubMed 39653344 Copy citation Copy BibTeX JAMA Psychiatry 2024-12-09 Ethan G. Dutcher, Andrew D. Krystal OpenAlex Published psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241303594 PubMed 39655749 Copy citation Copy BibTeX Unknown journal 2024-12-09 Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L Europe PMC Published psilocybin DepressionAnxietyEnd-of-Life Distress Randomized Controlled Trial More
Select for export Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 Pandemic Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamanetworkopen.2024.49026 PubMed 39636638 Copy citation Copy BibTeX JAMA Network Open 2024-12-04 Anthony L. Back, Timara K. Freeman-Young, Ladybird Morgan, Tanmeet Sethi, Kelsey K. Baker, Susanna Myers OpenAlex Published psilocybin DepressionPTSDChronic Pain Randomized Controlled Trial More
Select for export Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-024-03187-1 PubMed 39632810 Copy citation Copy BibTeX Unknown journal 2024-12-03 Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R Europe PMC Published psilocybinpsilocin DepressionAddictionBrain Imaging Systematic Review More
Select for export Consistent evidence that brain serotonin 2A receptor binding is positively associated with personality-based risk markers of depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjp.2024.143 PubMed 39632615 Copy citation Copy BibTeX Unknown journal 2024-12-03 Høgsted ES, Beliveau V, Ozenne B, Madsen MK, Svarer C, Dam VH Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Observational Study More
Select for export Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1146/annurev-psych-020124-023532 PubMed 39094057 Copy citation Copy BibTeX Unknown journal 2024-12-02 Humphreys K, Todd Korthuis P, Stjepanović D, Hall W. Europe PMC Published psilocybin DepressionPTSDAddiction Other More
Select for export Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1111/acps.13778 PubMed 39627679 Copy citation Copy BibTeX Unknown journal 2024-12-02 Menon V, Ramamurthy P, Venu S, Andrade C. Europe PMC Published psilocybin DepressionHeadache / MigraineRandomized Controlled Trial Randomized Controlled Trial More
Select for export Correction to: A Bayesian Reanalysis of a Trial of Psilocybin Versus Escitalopram for Depression by Nayak, et al. Psychedelic Med 2023;1(1):18-26; doi: 10.1089/psymed.2022.0002. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2022.0002.correx PubMed 40045987 Copy citation Copy BibTeX Unknown journal 2024-12-01 Authors unavailable Europe PMC Published psilocybin Depression Other More
Select for export Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1001/jamapsychiatry.2024.2546 PubMed 39230883 Copy citation Copy BibTeX Unknown journal 2024-11-30 Hinkle JT, Graziosi M, Nayak SM, Yaden DB. Europe PMC Published psilocybin DepressionAnxietyHeadache / Migraine Meta-Analysis More
Select for export Psychedelics for the Treatment of Obsessive-Compulsive Disorder: Efficacy and Proposed Mechanisms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyae057 PubMed 39611453 Copy citation Copy BibTeX Unknown journal 2024-11-30 Collins HM. Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Psilocybin and hallucinogenic mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1017/s1092852924002487 PubMed 39789676 Copy citation Copy BibTeX Unknown journal 2024-11-30 Fradet M, Kelly CM, Donnelly AJ, Suppes T. Europe PMC Published psilocybin DepressionPharmacologyAging Other More
Select for export Psilocybin as a Disease-Modifying Drug-A Salutogenic Approach in Psychiatry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3238/arztebl.m2024.0224 PubMed 39628414 Copy citation Copy BibTeX Unknown journal 2024-11-30 Spangemacher M, Mertens LJ, Färber LV, Jungaberle A, Jungaberle H, Gründer G. Europe PMC Published psilocybin DepressionAnxietyAddiction Randomized Controlled Trial More
Select for export Exploring Psychotherapeutic Benefits of Psilocybin and Psychedelics In Controlled Medical Settings Abstract available at the source but not redistributed here. Read at source. Details DOI 10.47611/jsrhs.v13i4.7602 Copy citation Copy BibTeX Journal of Student Research 2024-11-29 Arman Fard, Allison Cohen OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2024.11.28.625811 Copy citation Copy BibTeX bioRxiv 2024-11-27 Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B. bioRxiv PREPRINT (not peer reviewed) psilocybin DepressionNeuroplasticityReceptor Pharmacology Animal Study More
Select for export Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41380-024-02800-5 PubMed 39592825 Copy citation Copy BibTeX Unknown journal 2024-11-26 Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L Europe PMC Published psilocybin DepressionClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2024-11-18 TRYP Therapeutics ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1089/psymed.2024.0032 PubMed 40337756 Copy citation Copy BibTeX Psychedelic Medicine 2024-11-17 Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, Ryan M. Brudner, Fabiano A. Gomes, Marc G. Blainey OpenAlex Published psilocybin DepressionChronic PainTreatment-Resistant Depression Other More
